These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20723922)

  • 21. Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin.
    D'Hallewin MA; De Witte PA; Waelkens E; Merlevede W; Baert L
    J Urol; 2000 Aug; 164(2):349-51. PubMed ID: 10893582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optical coherence tomography for the characterization of basal cell carcinoma in vivo: a pilot study.
    Olmedo JM; Warschaw KE; Schmitt JM; Swanson DL
    J Am Acad Dermatol; 2006 Sep; 55(3):408-12. PubMed ID: 16908344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allelic loss of p53 gene is associated with genesis and maintenance, but not invasion, of mouse carcinoma in situ of the bladder.
    Cheng J; Huang H; Pak J; Shapiro E; Sun TT; Cordon-Cardo C; Waldman FM; Wu XR
    Cancer Res; 2003 Jan; 63(1):179-85. PubMed ID: 12517796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-resolution imaging of gynecologic neoplasms using optical coherence tomography.
    Pitris C; Goodman A; Boppart SA; Libus JJ; Fujimoto JG; Brezinski ME
    Obstet Gynecol; 1999 Jan; 93(1):135-9. PubMed ID: 9916971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3-D optical coherence tomography of the laryngeal mucosa.
    Bibas AG; Podoleanu AG; Cucu RG; Bonmarin M; Dobre GM; Ward VM; Odell E; Boxer A; Gleeson MJ; Jackson DA
    Clin Otolaryngol Allied Sci; 2004 Dec; 29(6):713-20. PubMed ID: 15533166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival of patients with carcinoma in situ of the urinary bladder.
    Cheng L; Cheville JC; Neumann RM; Leibovich BC; Egan KS; Spotts BE; Bostwick DG
    Cancer; 1999 Jun; 85(11):2469-74. PubMed ID: 10357420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optical coherence tomography of human kidney.
    Onozato ML; Andrews PM; Li Q; Jiang J; Cable A; Chen Y
    J Urol; 2010 May; 183(5):2090-4. PubMed ID: 20303512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ophthalmic imaging by spectral optical coherence tomography.
    Wojtkowski M; Bajraszewski T; Gorczyńska I; Targowski P; Kowalczyk A; Wasilewski W; Radzewicz C
    Am J Ophthalmol; 2004 Sep; 138(3):412-9. PubMed ID: 15364223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ.
    Horikawa Y; Sugano K; Shigyo M; Yamamoto H; Nakazono M; Fujimoto H; Kanai Y; Hirohashi S; Kakizoe T; Habuchi T; Kato T
    J Urol; 2003 Apr; 169(4):1541-5. PubMed ID: 12629411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
    Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
    Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on multiple mucosal biopsy in patients with bladder cancer. 2. Evaluation on the relationship between the results of multiple mucosal biopsy and recurrence, and the clinical course of cases with carcinoma in situ and micro-invasion of carcinoma in situ].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1633-47. PubMed ID: 3825813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optical distortion correction in optical coherence tomography for quantitative ocular anterior segment by three-dimensional imaging.
    Ortiz S; Siedlecki D; Grulkowski I; Remon L; Pascual D; Wojtkowski M; Marcos S
    Opt Express; 2010 Feb; 18(3):2782-96. PubMed ID: 20174107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectral optical coherence tomography in video-rate and 3D imaging of contact lens wear.
    Kaluzny BJ; Fojt W; Szkulmowska A; Bajraszewski T; Wojtkowski M; Kowalczyk A
    Optom Vis Sci; 2007 Dec; 84(12):1104-9. PubMed ID: 18091301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of optical coherence tomography imaging in the diagnosis of non-melanoma skin cancer and benign lesions versus normal skin: observer-blinded evaluation by dermatologists and pathologists.
    Mogensen M; Joergensen TM; Nürnberg BM; Morsy HA; Thomsen JB; Thrane L; Jemec GB
    Dermatol Surg; 2009 Jun; 35(6):965-72. PubMed ID: 19397661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical coherence tomography compared with histology of the main pancreatic duct structure in normal and pathological conditions: an 'ex vivo study'.
    Testoni PA; Mangiavillano B; Albarello L; Mariani A; Arcidiacono PG; Masci E; Doglioni C
    Dig Liver Dis; 2006 Sep; 38(9):688-95. PubMed ID: 16807151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Optical coherence tomography in diagnosis of urinary bladder cancer].
    Danil'chenko DI; Al'-Shukri AS; Tkachuk VN
    Urologiia; 2009; (2):42-4. PubMed ID: 19526873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. State-of-the-art retinal optical coherence tomography.
    Drexler W; Fujimoto JG
    Prog Retin Eye Res; 2008 Jan; 27(1):45-88. PubMed ID: 18036865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential changes of mouse bladder epithelium during induction of invasive carcinomas by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Ohtani M; Kakizoe T; Nishio Y; Sato S; Sugimura T; Fukushima S; Niijima T
    Cancer Res; 1986 Apr; 46(4 Pt 2):2001-4. PubMed ID: 3948177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.